Journal of Cell Science & Therapy
Open Access
ISSN: 2157-7013
+44 1300 500008
ISSN: 2157-7013
+44 1300 500008
Al-Aqeel A I
Riyadh Military Hospital, Kingdom of Saudi Arabia
Posters & Accepted Abstracts: J Cell Sci Ther
We are at a time of unprecedented increase in knowledge of rapidly changing technology. Such biotechnology especially when it involves human subjects raises complex ethical, legal, social, regulatory and religious issues. One of these advances is translational genomics being seen as the best new hope in the search for cures to diseases. However, this research raises sensitive ethical, regulatory and religious arguments which are balanced against possible great benefit of such research in regenerative medicine for patients suffering from so far incurable diseases. If the regulatory policies in each country are put forward for such research, the major remaining barriers to realizing the medical benefits of translational genomics might be the lack of skilled scientists in the field, the source of funding, pressure on researchers to develop commercialized products and to build links with industry and policies for sharing materials and data and for commercialization in the presence of informed consent. In conclusion the excitement over the scientific, medical and financial possibilities of translational genomics has been accompanied by ethical concerns therefore there is a need of developing international approaches to address these concerns across the continuum of such research from bench to bedside and to publication with the attention to global equity and benefit sharing.
Email: aalaqeel@rmh.med.sa